Spring Bank Pharmaceuticals Announces Proposed Public Offering of Common Stock

Go back to Spring Bank Pharmaceuticals Announces Proposed Public Offering of Common Stock

Spring Bank Pharmaceuticals (SBPH) Prices 2.88M Common Stock Offering at $13/Share

June 22, 2017 9:09 AM EDT

Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) (Spring Bank), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, cancer, and inflammatory diseases, announced today the pricing of its previously announced underwritten public offering of 2,884,615 shares of its common stock at... More